亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會(huì)員第1年

江蘇永健醫(yī)藥科技有限公司  

1、中藥化學(xué)對照品的研發(fā)、生產(chǎn)與銷售; 2、依客戶特點(diǎn)定制中藥單體化合物; 3、中藥(植物)提取物及質(zhì)量標(biāo)準(zhǔn)與工藝; 4、工藝技術(shù)合作、轉(zhuǎn)讓及新藥研發(fā); 5、名貴中藥個(gè)性化服務(wù)等。

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:丁先生
  • 電話:0523-89999279
  • QQ:1559451077
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 1-甲氧基-3-吲哚**
1-甲氧基-3-吲哚**
單價(jià) 2000.00 / 10mg對比
銷量 暫無
發(fā)貨 江蘇泰州市付款后3天內(nèi)
庫存 1000010mg起訂1010mg
品牌 江蘇永健醫(yī)藥
過期 長期有效
更新 2019-06-11 13:49
 
詳細(xì)信息
 
1-甲氧基-3-吲哚** Caulilexin C
Caulilexine C
1-Methoxy-1H-indole-3-acetonitrile
1-Methoxy-3-indoleacetonitrile
1-Methoxyindoleacetonitrile
30536-48-2 C11H10N2O 186.21   按需分裝 10mg 2000 鑒別用
©2025 江蘇永健醫(yī)藥科技有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:13122  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |